TransMedics (TMDX) Operating Leases (2021 - 2026)

TransMedics' Operating Leases history runs 6 years deep, the most recent figure standing at $2.9 million for Q1 2026.

• On a quarterly basis, Operating Leases fell 47.78% year-over-year to $2.9 million in Q1 2026; TTM through Mar 2026 was $2.9 million, a 47.78% decrease from a year earlier, with the FY2025 full-year figure at $3.6 million, down 42.76% from the prior year.
• Operating Leases retreated to $2.9 million in Q1 2026 per TMDX's latest filing, from $3.6 million in the prior quarter.
• Across five years, Operating Leases topped out at $8.5 million in Q1 2022 and bottomed at $2.9 million in Q1 2026.
• The 5-year median for Operating Leases is $7.1 million (2024), against an average of $6.6 million.
• Across the five-year window, Operating Leases increased 5.71% in 2023 and tumbled 47.78% in 2026, its largest moves.
• Year by year, Operating Leases stood at $7.4 million in 2022, then rose by 3.94% to $7.7 million in 2023, then declined by 18.92% to $6.2 million in 2024, then slumped by 42.76% to $3.6 million in 2025, then decreased by 19.4% to $2.9 million in 2026.
• Per Business Quant, the three latest TMDX Operating Leases figures stand at $2.9 million (Q1 2026), $3.6 million (Q4 2025), and $4.4 million (Q3 2025).